2008 Clinical Practice Guidelines - Canadian Diabetes Association

interventions to improve glycaemic control in patients with
type 2 diabetes. Lancet. 2004;363:1589-1597.
43. Svoren BM, Butler D, Levine BS, et al. Reducing acute adverse
outcomes in youths with type 1 diabetes: a randomized, controlled
trial. Pediatrics. 2003;112:914-922.
44. Piette JD,Weinberger M, McPhee SJ.The effect of automated
calls with telephone nurse follow-up on patient-centered outcomes
of diabetes care: a randomized, controlled trial. Med
Care. 2000;38:218-230.
45. Jones H, Edwards L,Vallis TM, et al. Changes in diabetes selfcare
behaviors make a difference in glycemic control: the
Diabetes Stages of Change (DiSC) study. Diabetes Care. 2003;
26:732-737.
46. Grey M, Boland EA, Davidson M, et al. Short-term effects of
coping skills training as adjunct to intensive therapy in adolescents.
Diabetes Care. 1998;21:902-908.
47. Fosbury JA, Bosley CM, Ryle A, et al. A trial of cognitive analytic
therapy in poorly controlled type 1 patients. Diabetes Care.
1997;20:959-964.
48. Wysocki T, Harris MA, Greco P, et al. Randomized, controlled
trial of behavior therapy for families of adolescents with insulindependent
diabetes mellitus. J Pediatric Psychol.2000; 25:23-33.
49. Norris SL, Engelgau MM, Narayan KM. Effectiveness of selfmanagement
training in type 2 diabetes: a systematic review of
randomized controlled trials. Diabetes Care. 2001;24:561-587.
50. Anderson BJ, Brackett J, Ho J, et al. An office-based intervention
to maintain parent-adolescent teamwork in diabetes management.
Impact on parent involvement, family conflict, and
subsequent glycemic control. Diabetes Care. 1999;22:713-721.
51. Greenfield S, Kaplan SH,Ware JE Jr, et al. Patients’ participation
in medical care: effects on blood sugar control and quality
of life in diabetes. J Gen Intern Med. 1988;3:448-457.
52. Gage H, Hampson S, Skinner TC, et al. Educational and psychosocial
programmes for adolescents with diabetes:
approaches, outcomes and cost-effectiveness. Patient Educ
Couns. 2004;53:333-346.
53. Ellis DA, Frey MA, Naar-King S, et al.The effects of multisystemic
therapy on diabetes stress among adolescents with
chronically poorly controlled type 1 diabetes: findings from a
randomized, controlled trial. Pediatrics. 2005;16:826-832.
54. Ellis DA, Frey MA, Naar-King S, et al. Use of multisystemic
therapy to improve regimen adherence among adolescents
with type 1 diabetes in chronic poor metabolic control: a randomized
controlled trial. Diabetes Care. 2005;28:1604-1610.
55. Lustman PJ, Freedland KE, Griffith LS, et al. Fluoxetine for
depression in diabetes: a randomized double-blind placebocontrolled
trial. Diabetes Care. 2000;23:618-623.
56. Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior
therapy for depression in type 2 diabetes mellitus. A randomized,
controlled trial. Ann Intern Med. 1998;129:613-621.
57. Fava M, Judge R, Hoog S, et al. Fluoxetine versus sertraline
and paroxetine in major depressive disorders: changes in
weight with long term treatment. J Clin Psychiatry. 2000;
61:863-867.
S85
MANAGEMENT